Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Imperva Inc Issues Q4 2012 Guidance; Revises FY 2012 Guidance


Thursday, 1 Nov 2012 04:06pm EDT 

Imperva Inc announced that for the fourth quarter of 2012, it expects total revenue to be in the range of $29.5-$30.0 million, non-GAAP operating income to be in the range of $0.5 million to $0.8 million and non-GAAP net income to be in the range of $0.3 million to $0.6 million, or a profit of $0.01 to $0.02 per share, which excludes stock-based compensation expense. For fiscal 2012, it expects total revenue to be in the range of $102.0-$102.5 million, non-GAAP operating loss to be in the range of $1.8-$2.1 million and non-GAAP net loss to be in the range of $2.4 million to $2.7 million, or a loss of $0.11 to $0.12, which excludes stock-based compensation expense. Imperva expects capital expenditures for the full year to be in the range of $2.0 million to $2.5 million. 

Company Quote

27.57
-0.24 -0.86%
2 Oct 2014